Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Edwards Lifesciences Q3 Adj. EPS $0.67 Beats $0.59 Estimate, Sales $1.553B Beat $1.495B Estimate

Author: Benzinga Newsdesk | October 30, 2025 03:14pm
Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.59 by 13.18 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.553 billion which beat the analyst consensus estimate of $1.495 billion by 3.90 percent. This is a 14.70 percent increase over sales of $1.354 billion the same period last year.

Posted In: EW


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist